Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
17.69
-0.17 (-0.95%)
At close: Oct 13, 2026, 4:00 PM EDT
17.55
-0.14 (-0.79%)
After-hours: Oct 13, 2026, 7:51 PM EDT
Beta Bionics Revenue
Beta Bionics had revenue of $32.01M in the quarter ending June 30, 2026, with 37.76% growth. This brings the company's revenue in the last twelve months to $119.01M, up 52.54% year-over-year. In the year 2025, Beta Bionics had annual revenue of $100.25M with 53.94% growth. That makes Beta Bionics the 21,314th largest company in the world by revenue and 3,183rd in the United States.
Revenue (ttm)
$119.01M
Revenue Growth
+52.54%
P/S Ratio
7.82
Revenue / Employee
$281,355
Employees
423
Market Cap
931.23M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.25M | 35.13M | 53.94% |
| Dec 31, 2024 | 65.12M | 53.13M | 442.93% |
| Dec 31, 2023 | 12.00M | 11.82M | 6,601.12% |
| Dec 31, 2022 | 179.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
BBNX News
- 1 day ago - Beta Bionics initiated with a Buy at Jefferies - TheFly
- 4 days ago - Kaplan Fox Urges Investors of Beta Bionics, Inc. (BBNX) to Seek a Leadership Role Before November 3, 2026 - Newsfile Corp
- 4 days ago - Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 3, 2026 - GlobeNewsWire
- 5 days ago - Kaplan Fox Encourages Beta Bionics, Inc. (BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026 - Newsfile Corp
- 7 days ago - Beta Bionics initiated with an Overweight at Barclays - TheFly
- 8 days ago - BBNX Court Notification: Beta Bionics has been Sued for Securities Fraud over Medical Device Safety Issues – BFA Law Reminds Investors of the November 3 Court Deadline - GlobeNewsWire
- 11 days ago - Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of an Upcoming Lead Plaintiff Deadline on November 3, 2026 - GlobeNewsWire
- 12 days ago - Kaplan Fox Alerts Beta Bionics, Inc. (BBNX) Investors to an Approaching Lead Plaintiff Deadline on November 3, 2026 - Newsfile Corp